Spectrum Clinical Research, began its operations in 2005. Our rich research experience, combined with our understanding and knowledge of the health care system in India, enables us to effectively meet the research needs of the pharmaceutical industry and CROs. Our principles, with their diverse experience in health related research, combined with the qualified medical professionals and scientific expertise and qualifications, has allowed us to provide our clients with high quality research services seamlessly across the Unites States and India.
International Standards
SCR project management personnel and Investigators support our aim of conducting studies that conform to the highest level of quality, compliance, ethical standards and patient care. SCR sites are run by experienced ICH-GCP trained Investigators and the infrastructure are monitored by SCR including laboratory equipment, IT and communications infrastructure. SCR provides complete operational and administrative support in addition to the training, recruitment and deployment of personnel.
SCR supports ICH-GCP compliant trials and accomplishes this through training the Investigators and staff for the same. We also provide expertise in meeting local regulatory standards in diverse therapeutic areas.
Centralized Training
SCR strongly emphasizes on quality by providing rigorous in-service training which is mandatory across all sites. All sites are trained in, and adhere to the Standard Operating Procedures (SOPs) and we perform regular internal audits of studies. Our SOPs also ensure a substantial reduction in Subject Drop Out rates.
ADVANTAGE INDIA
Completing clinical drug trials and product development in India could be up to 75% faster with its large patient populations, well-trained and enthusiastic investigators. Other factors as mentioned below, makes India an Ideal destination for participating in global drug development programs:
World-class patents regime in place, India is identified as a major resource center for conducting clinical trials and data management services.
Large pool of talented and GCP-trained investigator state-of-the-art medical and hospital facilities.
Conducting clinical trials in India has 30-50% lower cost compared to the West .
The source data is available in English.
Availability of a large pool of treatment-naïve patient.
Large diversity of patient population and disease states.
Indian research data generation is now accepted worldwide.
Well developed communication network with IT capabilities.
Facts & Figures
Number of Hospitals
14000
Number of Doctors
50000
Number of Hospital Beds
700000 ( 85% Urban )
Number of Medical Colleges
162
Number of Medical Graduates
17000 per year
Patient Population Estimates
Asthmatic Patients
40 Million
Diabetic Patients
34 Million
HIV Positive Patients
8-10 Million
Epileptic Patients
8 Million Cancer Patients 3 Million
Cardiac-related Deaths
2 Million
Alzheimer's Disease Patients
1.5 Million
Hypertensive Patients
15 Million
Schizophrenia Patients
1 Million
Bipolar Patients
12 Million
Anxiety Patients
150 Million
Depression Patients
80 Million
OUR SITES
Investigator Sites in therapeutic areas ranging from Oncology, Neuro-psychiatry, Cardiology, Endocrinology, Internal Medicine, Obstetrics & Gynecology, Pediatrics, Dermatology and Preventive Medicine & Wellness.
We are currently managing 7 Phase 3, Multi-country, Multi-site International Studies, part of the Global Clinical Development programs of various Multi-National Pharmaceutical Companies.
Gujarat
Baroda (Vadodara) - 2 Sites
Ahmedabad
Surat - 2 Sites
Anand
New Delhi
New Delhi
West Bengal
Calcutta
Maharashtra
Nagpur - 2 Sites
Kolhapur
Aurangabad
Solapur
Nasik
Rajasthan
Jaipur – Sites
Kerala
Calicut
Jammu & Kashmir
Shrinagar
Karnataka
Banglore
Tamil Nadu
Chennai
We have developed these centres with Standard Operating Procedures that are the best practices in the industry and operate with high ethical standards.
Investigators are provided with ICH-GCP training & Uniform SOP's are followed across all sites
